No Added Value of Duloxetine in Patients With Chronic Pain due to Hip or Knee Osteoarthritis: A Cluster‐Randomized Trial

por van den Driest, Jacoline J., Schiphof, Dieuwke, Koffeman, Aafke R., Koopmanschap, Marc A., Bindels, Patrick J. E., Bierma‐Zeinstra, Sita M. A.
Publicado 2022

Opioid prescriptions in patients with osteoarthritis: a population-based cohort study

por van den Driest, Jacoline J, Schiphof, Dieuwke, de Wilde, Marcel, Bindels, Patrick J E, van der Lei, Johan, Bierma-Zeinstra, Sita M A
Publicado 2020

Antidepressant and anticonvulsant prescription rates in patients with osteoarthritis: a population-based cohort study

por van den Driest, Jacoline J, Schiphof, Dieuwke, de Wilde, Marcel, Bindels, Patrick J E, van der Lei, Johan, Bierma-Zeinstra, Sita M A
Publicado 2020

Effectiveness and cost-effectiveness of duloxetine added to usual care for patients with chronic pain due to hip or knee osteoarthritis: protocol of a pragmatic open-label cluster...

por van den Driest, Jacoline J, Schiphof, Dieuwke, Luijsterburg, Pim A J, Koffeman, Aafke R, Koopmanschap, Marc A, Bindels, Patrick J E, Bierma-Zeinstra, Sita M A
Publicado 2017

Incidence and Prevalence of Knee Osteoarthritis Using Codified and Narrative Data From Electronic Health Records: A Population‐Based Study

por Arslan, Ilgin G., Damen, Jurgen, de Wilde, Marcel, van den Driest, Jacoline J., Bindels, Patrick J. E., van der Lei, Johan, Schiphof, Dieuwke, Bierma‐Zeinstra, Sita M. A.
Publicado 2022